Here's the live share price of Shilpa Medicare along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Shilpa Medicare has gained 7.45% CAGR. Over the past year, the corresponding return has been -7.47%.
Shilpa Medicare’s current P/E of 72.83x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Shilpa Medicare | -0.87 | -5.97 | -11.25 | 31.32 | -7.20 | 29.07 | 7.45 |
Sun Pharmaceutical Industries | 1.08 | -1.32 | -2.30 | -5.58 | -13.67 | 22.86 | 25.44 |
Divi's Laboratories | 0.84 | -1.39 | -6.98 | 7.26 | 11.48 | 19.38 | 13.39 |
Cipla | -0.48 | -0.53 | 3.50 | 4.23 | -6.88 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -1.63 | -3.25 | 8.69 | 15.50 | 2.40 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 0.49 | 3.70 | -0.64 | 13.92 | -1.18 | 17.09 | 7.19 |
Mankind Pharma | -1.56 | 3.97 | 9.17 | 18.23 | 4.67 | 21.72 | 12.52 |
Zydus Lifesciences | -0.55 | 4.77 | 7.79 | 15.71 | -6.91 | 42.05 | 21.62 |
Lupin | 3.72 | 4.15 | 5.54 | 3.02 | -9.66 | 48.04 | 14.81 |
Abbott India | -0.88 | -4.93 | -2.46 | 2.81 | 7.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.56 | 3.02 | 14.49 | 14.40 | -11.41 | 20.01 | 14.29 |
Aurobindo Pharma | 3.96 | 0.18 | -1.58 | -1.88 | -29.64 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -2.57 | 5.17 | 25.57 | 45.12 | 21.20 | 77.31 | 32.95 |
Laurus Labs | -0.17 | 3.44 | 35.51 | 53.95 | 78.57 | 20.10 | 27.14 |
Biocon | -1.06 | -1.13 | 2.14 | 7.85 | -4.10 | 7.35 | -3.86 |
Anthem Biosciences | 1.87 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
GlaxoSmithKline Pharmaceuticals | -3.13 | -1.60 | -15.60 | 1.95 | -1.96 | 24.23 | 9.16 |
Cohance Lifesciences | -0.02 | 10.08 | -0.30 | -12.87 | -14.37 | 28.96 | 21.52 |
Gland Pharma | 6.20 | 2.52 | 15.71 | 30.13 | 9.43 | -4.11 | 2.12 |
Ipca Laboratories | -0.22 | -5.32 | -3.38 | -0.34 | -9.99 | 14.97 | 3.52 |
Over the last one year, Shilpa Medicare has declined 7.20% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (11.48%), Cipla (-6.88%). From a 5 year perspective, Shilpa Medicare has underperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 838.46 | 830.65 |
10 | 840.62 | 835.52 |
20 | 851.94 | 843.89 |
50 | 871.4 | 853.01 |
100 | 836.33 | 834.81 |
200 | 786.41 | 792.48 |
In the latest quarter, Shilpa Medicare remained same as its previous close in promoter holding, while DII stake decreased to 7.46%, FII holding rose to 11.19%, and public shareholding moved down to 37.10% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Bandhan Small Cap Fund | 11,02,941 | 0.64 | 93.34 |
ICICI Prudential ELSS Tax Saver Fund | 10,32,968 | 0.61 | 87.41 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 9,63,149 | 1.32 | 81.51 |
WhiteOak Capital Mid Cap Fund | 1,46,041 | 0.35 | 12.36 |
Aditya Birla Sun Life Pharma & Healthcare Fund | 1,13,482 | 1.14 | 9.6 |
Aditya Birla Sun Life Small Cap Fund | 61,313 | 0.11 | 5.19 |
Aditya Birla Sun Life Retirement Fund - The 30s Plan | 39,550 | 0.82 | 3.35 |
ITI Pharma and Healthcare Fund | 24,784 | 0.92 | 2.1 |
WhiteOak Capital ELSS Tax Saver Fund | 17,272 | 0.36 | 1.46 |
Motilal Oswal BSE Healthcare ETF | 1,289 | 0.34 | 0.11 |
Date Time | Announcement |
---|---|
Sep 11, 2025, 9:30 PM IST | Shilpa Medicare L - Reg. 34 (1) Annual Report. |
Aug 28, 2025, 9:10 PM IST | Shilpa Medicare L - Dispatch Of Letters To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Tr |
Aug 26, 2025, 10:19 PM IST | Shilpa Medicare L - Announcement under Regulation 30 (LODR)-Dividend Updates |
Aug 26, 2025, 9:52 PM IST | Shilpa Medicare L - Business Responsibility and Sustainability Reporting (BRSR) |
Aug 26, 2025, 9:21 PM IST | Shilpa Medicare L - Annual Report |
Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 477.34 Cr. and Equity Capital is Rs. 9.78 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Shilpa Medicare is ₹827.55 as on Sep 16, 2025.
The Shilpa Medicare is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Shilpa Medicare is ₹8,092.69 Cr as on Sep 16, 2025.
Today’s highest and lowest price of Shilpa Medicare are ₹837.50 and ₹818.20.
The 52-week high/low is the highest and lowest price at which Shilpa Medicare stock has traded in the past 52-week or nearly a year. The 52-week high of Shilpa Medicare is ₹1,003.20 and 52-week low of Shilpa Medicare is ₹530.50 as on Sep 16, 2025.
The Shilpa Medicare has shown returns of 0.35% over the past day, -5.97% for the past month, -15.62% over 3 months, -7.47% over 1 year, 29.07% across 3 years, and 7.45% over 5 years.
P/E ratio of and PB ratio of Shilpa Medicare are 72.83 and 3.48 on Sep 16, 2025. While the company gives a dividend yield of 0.12 per annum.